Topics Related to Bulletins
The insulin glargine vial and insulin glargine Solostar® will be added as Preferred on the NC Medicaid Preferred Drug List, effective Jan. 27, 2023.
This bulletin replaces the Nov. 16, 2022, bulletin.
The latest updates on enrollees and services delivered, success stories and how Providers can refer Medicaid Members.
Effective Dec. 8, 2022
Effective Dec. 8, 2022
Open to providers who were due for reverification during the Public Health Emergency. Ends March 31.
Consolidates provider data management and furnishes a centralized solution to coordinate enrollment, credentialing and ongoing data maintenance.
Effective Dec. 1, 2022
An updated version effective Sept. 1, 2022, has been posted to the NC Medicaid Clinical Coverage Policy web page.
Point-of-sale (POS) billing for FDA-authorized over-the-counter (OTC) COVID-19 tests dispensed for use by NC Medicaid beneficiaries in a home setting remains in effect for NC Medicaid Direct and all five managed care plans.